Skip to Content

Notice

Advisory Committees; Tentative Schedule of Meetings for 2012

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing a Start Printed Page 78932tentative schedule of forthcoming meetings of its public advisory committees for 2012. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the Agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Teresa L. Hays, Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5290, Silver Spring, MD 20993, (301) 796-8220.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/​AdvisoryCommittees/​default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2012.

Table 1

Committee nameTentative date(s) of meeting(s)
OFFICE OF THE COMMISSIONER
Pediatric Advisory CommitteeJanuary 30-31, May & December date(s), if needed, to be determined.
Risk Communication Advisory CommitteeFebruary 13-14, April 30, May 1, August 16-17, November 1-2.
Science Board to FDAJanuary 6, May 2, October 3.
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory CommitteeApril 18, October 18.
Blood Products Advisory CommitteeFebruary 28-29, May 15-16, July 31-August 1, December 4-5.
Cellular, Tissue and Gene Therapies Advisory CommitteeFebruary 9-10, June 27-28, November 29-30.
Transmissible Spongiform Encephalopathies Advisory CommitteeDate(s), if needed, to be determined.
Vaccines and Related Biological Products Advisory CommitteeFebruary 28-29, May 16-17, September 19-20, November 14-15.
CENTER FOR DRUG EVALUATION AND RESEARCH
Anesthetic and Analgesic Drugs Advisory Committee (formerly the Anesthetic and Life Support Drugs Advisory Committee)February 9.
Anti-Infective Drugs Advisory CommitteeDate(s), if needed, to be determined.
Antiviral Drugs Advisory CommitteeMay 16-17.
Arthritis Advisory CommitteeMarch 12.
Cardiovascular and Renal Drugs Advisory CommitteeFebruary 23.
Dermatologic and Ophthalmic Drugs Advisory CommitteeFebruary 27.
Drug Safety and Risk Management Advisory CommitteeDate(s), if needed, to be determined.
Endocrinologic and Metabolic Drugs Advisory CommitteeFebruary 22, March 28-29.
Gastrointestinal Drugs Advisory CommitteeMarch 13-14.
Medical Imaging Drugs Advisory CommitteeDate(s), if needed, to be determined.
Nonprescription Drugs Advisory CommitteeDate(s), if needed, to be determined.
Oncologic Drugs Advisory CommitteeFebruary 8-9, March 20-21, June 20-21, July 24-25, September 12-13, November 6-7, December 4-5.
Peripheral and Central Nervous System Drugs Advisory CommitteeDate(s), if needed, to be determined.
Advisory Committee for Pharmaceutical Science and Clinical PharmacologyMarch 14.
Psychopharmacologic Drugs Advisory CommitteeDate(s), if needed, to be determined.
Pulmonary-Allergy Drugs Advisory CommitteeFebruary 23-24.
Advisory Committee for Reproductive Health DrugsJanuary 20, April 5.
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Medical Devices Advisory Committee (Comprised of 18 Panels)
Device Good Manufacturing Practices Advisory CommitteeDate(s), if needed, to be determined.
Anesthesiology and Respiratory Therapy Devices PanelJune 8, November 16.
Circulatory System Devices PanelDate(s), if needed, to be determined.
Clinical Chemistry and Clinical Toxicology Devices PanelApril 20, July 18-19, September 20-21.
Dental Products PanelDate(s), if needed, to be determined.
Ear, Nose, and Throat Devices PanelDate(s), if needed, to be determined.
Gastroenterology-Urology Devices PanelJuly 13.
General and Plastic Surgery Devices PanelJuly 17.
General Hospital and Personal Use Devices PanelAugust 16-17.
Hematology and Pathology Devices PanelJune 28.
Immunology Devices PanelDate(s), if needed, to be determined.
Start Printed Page 78933
Medical Devices Dispute Resolution PanelDate(s), if needed, to be determined.
Microbiology Devices PanelDate(s), if needed, to be determined.
Molecular and Clinical Genetics PanelJune 27.
Neurological Devices PanelDate(s), if needed, to be determined.
Obstetrics and Gynecology Devices PanelJuly 5-6.
Ophthalmic Devices PanelNovember 8-9.
Orthopedic and Rehabilitation Devices PanelSeptember 13-14, November 16, December 6-7.
Radiological Devices PanelNovember 2.
National Mammography Quality Assurance Advisory CommitteeOctober 18.
Technical Electronic Product Radiation Safety Standards CommitteeJune 14.
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory CommitteeDecember 13-14.
CENTER FOR TOBACCO PRODUCTS
Tobacco Products Scientific Advisory CommitteeJanuary 18-20, March 1-2.
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory CommitteeDate(s), if needed, to be determined.
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR)
Science Advisory Board to NCTROctober 23-24.
Start Signature

Dated: December 14, 2011.

Jill Hartzler Warner,

Acting Associate Commissioner for Special Medical Programs.

End Signature End Supplemental Information

[FR Doc. 2011-32469 Filed 12-19-11; 8:45 am]

BILLING CODE 4160-01-P